In this review we will overview the significance of the Phosphatidylinositol 3- kinase (PI3K) pathway in normal B cells and ALL, as well as preclinical and clinical evaluations of therapeutic drugs targeting PI3K in the context of ALL. This evidence concerns the gene PIK3CA and acute lymphoblastic leukemia.